Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections By Sam | March 25, 2018 Allecra Therapeutics released positive top-line data from its Phase II trial of AAI101, an antibiotic against gram-negative bacteria. Source: BioSpace Posted in BioPharma